Drug Repurposing for Triple-Negative Breast Cancer Ávalos Moreno, Marta López Tejada, Araceli Blaya Cánovas, José L. Cara Lupiáñez, Francisca E. González González, Adrián Lorente Acosta, José Antonio Sánchez Rovira, Pedro Granados Principal, Sergio Triple-negative breast cancer Personalized medicine Computational methods Drug repurposing Clinical trials Cancer stem cells 2021-02-08T10:47:16Z 2021-02-08T10:47:16Z 2020-10-29 journal article Ávalos-Moreno, M., López-Tejada, A., Blaya-Cánovas, J. L., Cara-Lupiañez, F. E., González-González, A., Lorente, J. A., ... & Granados-Principal, S. (2020). Drug repurposing for triple-negative breast cancer. Journal of Personalized Medicine, 10(4), 200. [doi:10.3390/jpm10040200] http://hdl.handle.net/10481/66380 10.3390/jpm10040200 eng http://creativecommons.org/licenses/by/3.0/es/ open access Atribución 3.0 España Mdpi